• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

恶性黑色素瘤:一种雄激素依赖性肿瘤?

Malignant melanoma: an androgen-dependent tumour?

作者信息

Rampen F H, Mulder J H

出版信息

Lancet. 1980 Mar 15;1(8168 Pt 1):562-4. doi: 10.1016/s0140-6736(80)91055-7.

DOI:10.1016/s0140-6736(80)91055-7
PMID:6102285
Abstract

Of 688 melanoma patients registered during 1956--78, 267 developed metastatic spread of the disease. Sex differences in the course of the disease in this subset were studied. Intervals between subsequent stages of melanoma activity were longer, but not significantly so, in female than male patients. Survival times from initial distant metastasis were significantly longer in women than in men. Tumour doubling time of pulmonary secondaries revealed a clear tendency to a slower growth rate in female patients. Our analysis suggests that malignant melanoma might be an androgen-dependent tumour. Therapy with anti-androgens or orchidectomy deserves consideration in male patients with metastatic melanoma.

摘要

在1956年至1978年登记的688例黑色素瘤患者中,有267例发生了疾病的转移扩散。对该亚组患者疾病进程中的性别差异进行了研究。黑色素瘤活动后续阶段之间的间隔在女性患者中比男性患者更长,但差异不显著。从初始远处转移开始计算的生存时间,女性明显长于男性。肺转移瘤的肿瘤倍增时间显示,女性患者的生长速度有明显减缓的趋势。我们的分析表明,恶性黑色素瘤可能是一种雄激素依赖性肿瘤。对于转移性黑色素瘤男性患者,抗雄激素治疗或睾丸切除术值得考虑。

相似文献

1
Malignant melanoma: an androgen-dependent tumour?恶性黑色素瘤:一种雄激素依赖性肿瘤?
Lancet. 1980 Mar 15;1(8168 Pt 1):562-4. doi: 10.1016/s0140-6736(80)91055-7.
2
Sex differences in survival from cutaneous melanoma.皮肤黑色素瘤生存率的性别差异。
Int J Dermatol. 1984 Sep;23(7):444-52. doi: 10.1111/ijd.1984.23.7.444.
3
A multifactorial analysis of melanoma. IV. Prognostic factors in 200 melanoma patients with distant metastases (stage III).黑色素瘤的多因素分析。IV. 200例有远处转移(III期)黑色素瘤患者的预后因素
J Clin Oncol. 1983 Feb;1(2):126-34. doi: 10.1200/JCO.1983.1.2.126.
4
Malignant melanoma: sex differences in survival after evidence of distant metastasis.恶性黑色素瘤:远处转移证据出现后的生存性别差异。
Br J Cancer. 1980 Jul;42(1):52-7. doi: 10.1038/bjc.1980.202.
5
Immunohistochemically detectable bcl-2 expression in metastatic melanoma: association with survival and treatment response.转移性黑色素瘤中免疫组化可检测到的bcl-2表达:与生存及治疗反应的关联
Oncology. 2002;62(3):259-68. doi: 10.1159/000059574.
6
Survival after pulmonary metastasectomy in patients with malignant melanoma.恶性黑色素瘤患者肺转移瘤切除术后的生存率
Thorac Cardiovasc Surg. 2011 Apr;59(3):158-62. doi: 10.1055/s-0030-1250669. Epub 2011 Apr 8.
7
CXCR3 chemokine receptor immunoreactivity in primary cutaneous malignant melanoma: correlation with clinicopathological prognostic factors.原发性皮肤恶性黑色素瘤中CXCR3趋化因子受体免疫反应性:与临床病理预后因素的相关性
J Clin Pathol. 2007 Jun;60(6):596-9. doi: 10.1136/jcp.2005.032144. Epub 2006 Mar 7.
8
Soluble ICAM-1 seems to be related to prognosis in malignant melanoma.可溶性细胞间黏附分子-1似乎与恶性黑色素瘤的预后相关。
J Eur Acad Dermatol Venereol. 1999 May;12(3):264-6. doi: 10.1111/j.1468-3083.1999.tb01043.x.
9
Stage-IV melanoma and pulmonary metastases: factors predictive of survival.IV期黑色素瘤和肺转移:生存预测因素
Ann Surg Oncol. 2007 Oct;14(10):2847-53. doi: 10.1245/s10434-007-9448-y. Epub 2007 Aug 7.
10
Improved survival with pulmonary metastasectomy: an analysis of 1720 patients with pulmonary metastatic melanoma.肺转移瘤切除术改善生存:1720例肺转移性黑色素瘤患者的分析
J Thorac Cardiovasc Surg. 2007 Jan;133(1):104-10. doi: 10.1016/j.jtcvs.2006.08.065.

引用本文的文献

1
Androgen receptor signalling in non-prostatic malignancies: challenges and opportunities.非前列腺恶性肿瘤中的雄激素受体信号传导:挑战与机遇
Nat Rev Cancer. 2025 Feb;25(2):93-108. doi: 10.1038/s41568-024-00772-w. Epub 2024 Nov 25.
2
Sex differences in cancer and immunotherapy outcomes: the role of androgen receptor.癌症和免疫疗法疗效的性别差异:雄激素受体的作用。
Front Immunol. 2024 May 28;15:1416941. doi: 10.3389/fimmu.2024.1416941. eCollection 2024.
3
Androgen receptor is a determinant of melanoma targeted drug resistance.雄激素受体是黑色素瘤靶向药物耐药的决定因素。
Nat Commun. 2023 Oct 14;14(1):6498. doi: 10.1038/s41467-023-42239-w.
4
Uncovering the complex relationship between balding, testosterone and skin cancers in men.揭示男性脱发、睾酮与皮肤癌之间的复杂关系。
Nat Commun. 2023 Oct 3;14(1):5962. doi: 10.1038/s41467-023-41231-8.
5
Stranger Things: New Roles and Opportunities for Androgen Receptor in Oncology Beyond Prostate Cancer.《怪奇物语》:雄激素受体在肿瘤学中除前列腺癌以外的新角色和新机遇
Endocrinology. 2023 Apr 17;164(6). doi: 10.1210/endocr/bqad071.
6
Cutaneous Melanoma and Hormones: Focus on Sex Differences and the Testis.皮肤黑色素瘤与激素:关注性别差异和睾丸。
Int J Mol Sci. 2022 Dec 29;24(1):599. doi: 10.3390/ijms24010599.
7
Association between melanoma and exposure to sex hormones in puberty: A possible window of susceptibility (Review).黑色素瘤与青春期性激素暴露之间的关联:一个可能的易感性窗口(综述)
Mol Clin Oncol. 2021 Apr;14(4):66. doi: 10.3892/mco.2021.2228. Epub 2021 Feb 8.
8
Sustained androgen receptor signaling is a determinant of melanoma cell growth potential and tumorigenesis.持续的雄激素受体信号是黑色素瘤细胞生长潜力和肿瘤发生的决定因素。
J Exp Med. 2021 Feb 1;218(2). doi: 10.1084/jem.20201137.
9
Skin Melanoma and Subsequent Risk of Prostate Cancer: A Lithuanian Cancer Registry Study.皮肤黑色素瘤与前列腺癌发病风险:立陶宛癌症登记研究。
Int J Environ Res Public Health. 2019 Oct 15;16(20):3915. doi: 10.3390/ijerph16203915.
10
Melanoma patients with additional primary cancers: a single-center retrospective analysis.伴有其他原发性癌症的黑色素瘤患者:一项单中心回顾性分析。
Oncotarget. 2019 May 21;10(36):3373-3384. doi: 10.18632/oncotarget.26931.